CCND1 and nasopharyngeal carcinoma: Lai et al reported that rates of early local recurrence (within 5 years) were significantly higher (P < 0.01) for NPC patients with high levels of cyclin D1 before radiation therapy (24 of 35 patients (68.6%)) as compared with patients with low or no expression (three of 29 (10.3%)).